GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $582,000 | 0.0% | 13,368 | 0.0% | 0.04% | +19.4% |
| Q1 2022 | $582,000 | +23.0% | 13,368 | +24.7% | 0.04% | +28.6% |
| Q4 2021 | $473,000 | +16.5% | 10,718 | +0.9% | 0.03% | +3.7% |
| Q3 2021 | $406,000 | -7.5% | 10,618 | -3.6% | 0.03% | -3.6% |
| Q2 2021 | $439,000 | +13.1% | 11,018 | +1.4% | 0.03% | +7.7% |
| Q1 2021 | $388,000 | -16.9% | 10,868 | -14.4% | 0.03% | -18.8% |
| Q4 2020 | $467,000 | -2.3% | 12,696 | 0.0% | 0.03% | -8.6% |
| Q3 2020 | $478,000 | -7.7% | 12,696 | -0.0% | 0.04% | -14.6% |
| Q2 2020 | $518,000 | +7.7% | 12,697 | 0.0% | 0.04% | -6.8% |
| Q1 2020 | $481,000 | -21.8% | 12,697 | -3.0% | 0.04% | -8.3% |
| Q4 2019 | $615,000 | -8.9% | 13,086 | -17.3% | 0.05% | -12.7% |
| Q3 2019 | $675,000 | +6.6% | 15,818 | +0.1% | 0.06% | +1.9% |
| Q2 2019 | $633,000 | -8.3% | 15,807 | -4.3% | 0.05% | -11.5% |
| Q1 2019 | $690,000 | +10.0% | 16,519 | +0.7% | 0.06% | -3.2% |
| Q4 2018 | $627,000 | -17.8% | 16,408 | -13.6% | 0.06% | -11.3% |
| Q3 2018 | $763,000 | -1.9% | 18,999 | -1.5% | 0.07% | -9.0% |
| Q2 2018 | $778,000 | -1.3% | 19,296 | -4.3% | 0.08% | 0.0% |
| Q1 2018 | $788,000 | +9.6% | 20,162 | -0.5% | 0.08% | +14.7% |
| Q4 2017 | $719,000 | -13.0% | 20,268 | -0.3% | 0.07% | -20.0% |
| Q3 2017 | $826,000 | -24.7% | 20,334 | -20.1% | 0.08% | -26.1% |
| Q2 2017 | $1,097,000 | +4.9% | 25,450 | +2.6% | 0.12% | +4.5% |
| Q1 2017 | $1,046,000 | +3.4% | 24,812 | -5.6% | 0.11% | -1.8% |
| Q4 2016 | $1,012,000 | -8.7% | 26,272 | +2.3% | 0.11% | -6.7% |
| Q3 2016 | $1,108,000 | +0.5% | 25,693 | +0.9% | 0.12% | 0.0% |
| Q2 2016 | $1,103,000 | +3.7% | 25,452 | -3.0% | 0.12% | +1.7% |
| Q1 2016 | $1,064,000 | -2.6% | 26,227 | -3.1% | 0.12% | -2.5% |
| Q4 2015 | $1,092,000 | -2.0% | 27,053 | -6.6% | 0.12% | -5.5% |
| Q3 2015 | $1,114,000 | -27.7% | 28,980 | -21.7% | 0.13% | -20.0% |
| Q2 2015 | $1,541,000 | -7.6% | 37,009 | +2.4% | 0.16% | -7.5% |
| Q1 2015 | $1,667,000 | +3.2% | 36,126 | -4.4% | 0.17% | +3.6% |
| Q4 2014 | $1,616,000 | -4.4% | 37,800 | +2.7% | 0.17% | -10.7% |
| Q3 2014 | $1,691,000 | -17.1% | 36,794 | -3.6% | 0.19% | -18.0% |
| Q2 2014 | $2,041,000 | -0.1% | 38,167 | -0.2% | 0.23% | -4.2% |
| Q1 2014 | $2,044,000 | -5.2% | 38,257 | -5.2% | 0.24% | -6.3% |
| Q4 2013 | $2,155,000 | -1.3% | 40,356 | -7.2% | 0.25% | -9.6% |
| Q3 2013 | $2,183,000 | -0.2% | 43,506 | -0.6% | 0.28% | -2.8% |
| Q2 2013 | $2,188,000 | – | 43,780 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |